SCHEMBL2556313

SCHEMBL2556313

CC(=O)Nc1ccc(Nc2cccc(B(O)O)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.62
POLB P06746 1/20 0.62
MTNR1A P48039 1/20 0.60
MTNR1B P49286 1/20 0.60
HSD17B10 Q99714 2/20 0.50
NAPRT Q6XQN6 1/20 0.50
KMT2A Q03164 4/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
TAAR1 Q96RJ0 1/20 0.49
MEN1 O00255 3/20 0.48
GAA P10253 2/20 0.48
GFER P55789 1/20 0.48
ALDH1A1 P00352 4/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8930 0.89 ALDH1A1 (0.59) MAPTPOLBHSD17B10NAPRTKMT2A
SCHEMBL9479267 0.82 MAPT (0.85) MAPTPOLBMTNR1AMTNR1BHSD17B10
SCHEMBL15962127 0.81 SMN1; SMN2 (0.59) MAPTPOLBHSD17B10NAPRTKMT2A
SCHEMBL31416639 0.81 SMN1; SMN2 (0.59) MAPTPOLBHSD17B10NAPRTKMT2A
SCHEMBL1557346 0.79 ALDH1A1 (0.60) MAPTHSD17B10KMT2AMEN1GAA
SCHEMBL9479960 0.78 MAPT (0.79) MAPTPOLBMTNR1AMTNR1BHSD17B10
SCHEMBL28407305 0.78 ENPP2 (0.61) MAPTMTNR1AMTNR1BKMT2ANPC1
SCHEMBL9480198 0.77 MAPT (1.00) MAPTPOLBMTNR1AMTNR1BHSD17B10
SCHEMBL9162 0.77 SMN1; SMN2 (0.61) MAPTPOLBHSD17B10NAPRTKMT2A
SCHEMBL9479532 0.77 MAPT (1.00) MAPTPOLBMTNR1AMTNR1BHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
WO-2009155527-A9 PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS PROGENICS PHARMACEUTICALS, INC. (US) 2010-05-06 WO disclosed
WO-2009155527-A2 PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS PROGENICS PHARMACEUTICALS, INC. (US) 2009-12-23 WO disclosed